Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: AstraZeneca CFO makes $1.5m sale, IHG chair buys in
(Sharecast News) - At the top of the list of FTSE 350 director sells on Tuesday was AstraZeneca, whose chief financial officer sold almost $1.5m worth of the company's American depositary shares. The pharmaceuticals giant said Aradhana Sarin sold 19,470 of the shares on 5 May, at a price of $74.81 each.
That valued the transaction at a total of $1,456,550.70.
Two of AstraZeneca's American depositary shares are equivalent to one of its ordinary shares, the firm said in its disclosure.
On the buying side of things, the non-executive chair of InterContinental Hotels Group was also dealing in American depositary instruments, spending almost $0.35m.
The owner of brands including Holiday Inn said Deanna Oppenheimer acquired 5,000 of its American depositary receipts on the New York Stock Exchange on 8 May.
Oppenheimer paid $68.89 for each ADR, valuing the purchase at $344,450 in total.
At 1437 BST, shares in AstraZeneca were up 0.11% in London at 11,884p, while those in InterContinental Hotels Group were 0.6% firmer at 5,442p.
Reporting by Josh White for Sharecast.com.
DIRECTOR SELLS
Company: AstraZeneca Name: Aradhana Sarin Volume: 19,470 Price: $74.81 Value: $1,456,550.70
Company: London Stock Exchange Group Name: York Holdings II Volume: 9,048 Price: 8,359.77p Value: £756,391.99
DIRECTOR BUYS
Company: InterContinental Hotels Group Name: Deanna Oppenheimer Volume: 5,000 Price: $68.89 Value: $344,450.00
Company: CRH Name: Christina Verchere Volume: 1,000 Price: 3,824.4p Value: £38,244.00
Company: Videndum Name: Andrea Rigamonti Volume: 3,500 Price: 789.86p Value: £27,645.07
Company: InterContinental Hotels Group Name: Graham Allan Volume: 300 Price: 5,418.36p Value: £16,255.09
Company: Marshalls Name: Martyn Coffey Volume: 10,000 Price: 156p Value: £15,600.00
Company: InterContinental Hotels Group Name: Duriya Farooqui Volume: 200 Price: $68.625 Value: $13,725.00
Company: InterContinental Hotels Group Name: Daniela Barone Soares Volume: 150 Price: 5,427.55p Value: £8,141.33
Company: Marshalls Name: Alison Lockwood Volume: 3,763 Price: 164p Value: £6,171.32
Company: Marshalls Name: Amanda Bourne Volume: 1,062 Price: 280p Value: £2,973.60
Company: CMC Markets Name: Euan William Marshall Volume: 164 Price: 181.99p Value: £298.46
Company: CMC Markets Name: David John Fineberg Volume: 164 Price: 181.99p Value: £298.46
Company: Moneysupermarket.com Group Name: Matthew Cresswell Volume: 56 Price: 267.3p Value: £149.69
Company: Moneysupermarket.com Group Name: Peter Duffy Volume: 56 Price: 267.3p Value: £149.69
Company: Moneysupermarket.com Group Name: Matthew Whittle Volume: 38 Price: 267.3p Value: £101.57
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
